Quality of Life After Rectal Cancer Surgery

Sponsor
Dr. Lutfi Kirdar Kartal Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04455945
Collaborator
(none)
2
1
41.6
0

Study Details

Study Description

Brief Summary

Following colorectal surgery, many patients face a combination of physical and emotional problems for a long period of time. Symptoms such as pain, fatigue, and disturbed bowel and sexual function, as well as problems in social and role functioning, inevitably affect the patients' well-being. Therefore, evaluation of the self-reported quality of life (QoL) is becoming increasingly important in clinical trials. The investigators aimed to compare long term health related life quality (HRQoL) results of laparoscopic approach with open approach in patients with sphincter preserving resections for rectal cancer at a single-center.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Open Rectal cancer surgery
  • Procedure: Laparoscopic Rectal cancer surgery

Detailed Description

This study is planned prospectively. All patients scheduled for operation due to rectal cancer in our clinic between January 2017 and December 2018 will be evaluated for suitability for the study. During the preoperative examination, patients will be informed about the study and their written consent will be obtained. Patients will be randomized between open and laparoscopic groups in the ratio 2:1, depending on the type of surgery. Clinical data of patients will be analyzed from the hospital database programme.

The EORTC QLQ-C30 and QLQ-CR29 questionnaires prepared by The European Organization for Research and Treatment of Cancer (EORTC) will be used to evaluate the quality of life after the operation. The EORTC QLQ-C30 questionnaire will be completed by examining the patients' daily observation notes. EORTC QLQ-CR29 will be completed with face to face interviews in the first year after surgery.

In this way, it will be aimed to compare the early and long-term quality of life (HRQoL) results of open and laparoscopic approach in patients undergoing surgery for rectal cancer.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
2 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Comparison of Quality of Life Outcomes Between Laparoscopic and Open Approach for Rectal Cancer Surgery
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Dec 31, 2018
Actual Study Completion Date :
Jun 19, 2020

Arms and Interventions

Arm Intervention/Treatment
Open

Patients with open surgery for rectal cancer planned in our department.

Procedure: Open Rectal cancer surgery
Open sphincter preserving surgery for rectal cancer

Laparoscopic

Patients with laparoscopic surgery for rectal cancer planned in our department.

Procedure: Laparoscopic Rectal cancer surgery
Laparoscopic sphincter preserving surgery for rectal cancer

Outcome Measures

Primary Outcome Measures

  1. Age [Before surgery]

    Years

  2. Gender [Before surgery]

    Male/Female

  3. BMI [Before surgery]

    kg/m²

  4. ASA [Before surgery]

    I, II, III, IV

  5. Tumor Localization [During the operation]

    Upper/Middle/Low

  6. Pathologic Stage [up to 10 days after surgery]

    1A, 1B, 2A, 2B, 3A, 3B, 3C

  7. Complications [Through study completion, an average of 1 year]

    yes/no

  8. European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) Functional scales [During one week after surgery]

    Global/Physical/Role/Cognitive/Social functioning. All scales and single-item measurements range from 0 to 100. A higher score on a functional scale indicates better functioning.

  9. European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) Symptom scales [During one week after surgery]

    Fatigue/Nausea and vomiting/Pain/Dyspnoea/Insomnia/Appetite loss/Constipation/Diarrhoea/Financial difficulties. All scales and single-item measurements range from 0 to 100. A higher score for a symptom scale / item indicates a higher symptomatology and problem level.

  10. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Colorectal Cancer 29 (EORTC QLQ-CR29) Functional scales [During one year after surgery]

    Body Image/Future projections/Weight/Sexual interest. All scales and single-item measurements range from 0 to 100. A higher score on a functional scale indicates better functioning.

  11. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Colorectal Cancer 29 (EORTC QLQ-CR29) Symptom scales [During one year after surgery]

    Urinary frequency/Blood and mucus in stool/Stool frequency/Urinary incontinence/Dysuria/Abdominal pain/Buttock pain/Bloating/Dry mouth/Hair loss/Taste/Flatulence/Faecal incontinence/Sore skin/Embarrassment/Impotence/Dyspareunia. All scales and single-item measurements range from 0 to 100. A higher score for a symptom scale / item indicates a higher symptomatology and problem level.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients who underwent surgery (laparoscopic or open) for rectal cancer in our department.
Exclusion Criteria:
  • The patients whose all oncological treatments had not been completed at least 6 months ago

  • The patients with ASA IV score

  • The patients with previous abdominal surgery

  • The patients who had developed major surgical complications (such as anastomosis leakage, requiring re-laparotomy, evisceration)

  • The patients who underwent a new abdominal surgery except for stoma closure

  • The patients with local recurrence or distant metastases

  • The patients who still had a stoma

  • The patients who did not want to take part in the study

  • The patients who missed in the follow-up period

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kartal Dr Lutfi Kirdar Tranining and Research Hospital Istanbul Turkey 34890

Sponsors and Collaborators

  • Dr. Lutfi Kirdar Kartal Training and Research Hospital

Investigators

  • Study Chair: Selcuk Kaya, MD, Kartal Dr. Lutfi Kirdar Training and Research Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ramazan Sari, Principal Investigator, Dr. Lutfi Kirdar Kartal Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT04455945
Other Study ID Numbers:
  • 2017/514/108/12
First Posted:
Jul 2, 2020
Last Update Posted:
Jul 2, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ramazan Sari, Principal Investigator, Dr. Lutfi Kirdar Kartal Training and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 2, 2020